Versor Investments’s Lindsay Corp LNN Stock Holding History

Versor Investments’s Portfolio LNN Stock Details LNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,502	Closed	-$361K	–	810
2025 Q2	$361K	Buy	+2,502	New	+$334K	0.06%	488
2024 Q2	–	Sell	-3,400	Closed	-$400K	–	840
2024 Q1	$400K	Sell	3,400 -800	-19%	-$99.4K	0.08%	406
2023 Q4	$542K	Buy	+4,200	New	+$515K	0.11%	310

Other funds holding LNN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PWA

Prairie Wealth Advisors Omaha, Nebraska $231M AUM 23.67% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Versor Investments's LNN Position: Q3 2025 in Review

Versor Investments sold out of Lindsay Corp (LNN) in Q3 2025, closing a stake of 2,502 shares — an estimated $361K sold.

Versor Investments first reported a position in LNN in Q4 2023 and held it in 3 quarters. The position peaked at $542K in Q4 2023. 241 funds tracked by Wall St. Rank hold LNN as of Q3 2025.

Versor Investments reported no remaining Lindsay Corp position as of Q3 2025 after selling out during the quarter.
Versor Investments sold 2,502 Lindsay Corp shares in Q3 2025, an estimated $361K.
Versor Investments first reported a position in Lindsay Corp in Q4 2023 and held it in 3 quarters.
Versor Investments's Lindsay Corp position peaked at $542K in Q4 2023.
241 funds tracked by Wall St. Rank held Lindsay Corp as of Q3 2025.

Based on Versor Investments's 13F filing for Q3 2025, filed 6 Nov 2025.